Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Modulation of endothelial glycocalyx structure under inflammatory conditions

H. Kolářová, B. Ambrůzová, L. Svihálková Šindlerová, A. Klinke, L. Kubala,

. 2014 ; 2014 (-) : 694312.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

The glycocalyx of the endothelium is an intravascular compartment that creates a barrier between circulating blood and the vessel wall. The glycocalyx is suggested to play an important role in numerous physiological processes including the regulation of vascular permeability, the prevention of the margination of blood cells to the vessel wall, and the transmission of shear stress. Various theoretical models and experimental approaches provide data about changes to the structure and functions of the glycocalyx under various types of inflammatory conditions. These alterations are suggested to promote inflammatory processes in vessels and contribute to the pathogenesis of number of diseases. In this review we summarize current knowledge about the modulation of the glycocalyx under inflammatory conditions and the consequences for the course of inflammation in vessels. The structure and functions of endothelial glycocalyx are briefly discussed in the context of methodological approaches regarding the determination of endothelial glycocalyx and the uncertainty and challenges involved in glycocalyx structure determination. In addition, the modulation of glycocalyx structure under inflammatory conditions and the possible consequences for pathogenesis of selected diseases and medical conditions (in particular, diabetes, atherosclerosis, ischemia/reperfusion, and sepsis) are summarized. Finally, therapeutic strategies to ameliorate glycocalyx dysfunction suggested by various authors are discussed.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008064
003      
CZ-PrNML
005      
20150331101419.0
007      
ta
008      
150306s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2014/694312 $2 doi
035    __
$a (PubMed)24803742
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kolářová, Hana $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolska 135, 612 65 Brno, Czech Republic ; International Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, 656 91 Brno, Czech Republic.
245    10
$a Modulation of endothelial glycocalyx structure under inflammatory conditions / $c H. Kolářová, B. Ambrůzová, L. Svihálková Šindlerová, A. Klinke, L. Kubala,
520    9_
$a The glycocalyx of the endothelium is an intravascular compartment that creates a barrier between circulating blood and the vessel wall. The glycocalyx is suggested to play an important role in numerous physiological processes including the regulation of vascular permeability, the prevention of the margination of blood cells to the vessel wall, and the transmission of shear stress. Various theoretical models and experimental approaches provide data about changes to the structure and functions of the glycocalyx under various types of inflammatory conditions. These alterations are suggested to promote inflammatory processes in vessels and contribute to the pathogenesis of number of diseases. In this review we summarize current knowledge about the modulation of the glycocalyx under inflammatory conditions and the consequences for the course of inflammation in vessels. The structure and functions of endothelial glycocalyx are briefly discussed in the context of methodological approaches regarding the determination of endothelial glycocalyx and the uncertainty and challenges involved in glycocalyx structure determination. In addition, the modulation of glycocalyx structure under inflammatory conditions and the possible consequences for pathogenesis of selected diseases and medical conditions (in particular, diabetes, atherosclerosis, ischemia/reperfusion, and sepsis) are summarized. Finally, therapeutic strategies to ameliorate glycocalyx dysfunction suggested by various authors are discussed.
650    _2
$a zvířata $7 D000818
650    _2
$a cévní endotel $x metabolismus $x patologie $7 D004730
650    _2
$a glykokalyx $x metabolismus $x patologie $7 D019276
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x metabolismus $x patologie $7 D007249
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Ambrůzová, Barbora $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolska 135, 612 65 Brno, Czech Republic ; Institute of Experimental Biology, Department of Physiology and Immunology of Animals, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic. $7 gn_A_00005476
700    1_
$a Svihálková Šindlerová, Lenka $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolska 135, 612 65 Brno, Czech Republic ; International Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, 656 91 Brno, Czech Republic.
700    1_
$a Klinke, Anna $u Heart Center, Department of Cardiology and Cologne Cardiovascular Research Center, University of Cologne, 50937 Cologne, Germany.
700    1_
$a Kubala, Lukáš $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Kralovopolska 135, 612 65 Brno, Czech Republic ; International Clinical Research Center, Center of Biomolecular and Cellular Engineering, St. Anne's University Hospital Brno, 656 91 Brno, Czech Republic.
773    0_
$w MED00006378 $t Mediators of inflammation $x 1466-1861 $g Roč. 2014, č. - (2014), s. 694312
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24803742 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150331101648 $b ABA008
999    __
$a ok $b bmc $g 1065337 $s 890864
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 2014 $c - $d 694312 $i 1466-1861 $m Mediators of inflammation $n Mediators Inflamm $x MED00006378
LZP    __
$a Pubmed-20150306

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...